Legislative mandate exists to address unfair prices in pharma sector, says EU enforcer
Credit: iStock/FotografiaBasica
Despite the difficulty of pursuing excessive-pricing cases in the pharmaceuticals sector, the European Commission has a legislative mandate to go after such concerns, a director at the EU enforcer has said.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now